LinkedInFacebookFind us on youtubeTwitter
Free Monthly Newsletters click here to sign up     click here to sign up

Rochelle Sampy

Patients Editor at eyeforpharma

Biography

Rochelle Sampy is our resident Patients Editor.

 

Rochelle graduated from the University of Surrey with a 2.1 in Law with International Studies.

 

Previously Rochelle has written for Bauer Media and the South African newspaper and has contributed to the 7th edition CIPA Guide to the Patents Act by the Chartered Institute of Patent Attorneys as well as working for the European Healthcare Fraud and Corruption Network, Brussels.

 

Articles

Articles

Prescription drug bulk purchasing agreements can save patients money but could hinder their health outcomes as a result of reduced access to favourable medicines.
(May 15, 2013)
An innovative form of 3D technology could eliminate atrial fibrillation caused by the electronic signals in the heart, a major step forward in the treatment of this condition.
(May 13, 2013)
A US comprehensive Cancer Centre has discovered that a biological data facility can accelerate recruitment, lower costs, minimise trial size and expedite the testing of medicines during drug development.
(May 8, 2013)
A three-dimensional ‘heart patch’ is the world’s first synthetically grown human heart muscle, an accurate estimate of traditional human heart tissue that can help test multiple new therapies for affected patients.
(May 7, 2013)
An analysis of oncology clinical research data uncovers the worrying disparity between incidence and mortality of cancer, and the volume of research conducted in these key areas.
(May 1, 2013)
The global pharmaceutical industry can expect a growth in earnings this year, as their position in the market remains constant over the next 12 – 18 months.
(Apr 25, 2013)
Several cancer metabolic expression changes have been discovered through a US study analysing gene expression data sourced from 22 types of tumours.
(Apr 22, 2013)
Diabetes research is more focused on advancing drug therapies than preventative measures and is likely to exclude older people and young children, a US study demonstrates.
(Apr 10, 2013)
A unique drug combination has elicited ground-breaking anti-tumour effects in patients with incurable BRCA-deficient cancers.
(Apr 9, 2013)
Pharmaceutical direct-to-consumer advertising (DTC) dropped by 11.5% last year which was a $2 billion drop from its peak in 2006.
(Apr 3, 2013)